Heiko Michael

Q: What is Heiko Michael email address?

Email Heiko Michael at heiko.michael@googlemail.com and heiko.michael@sanofi-aventis.com. This email is the most updated Heiko Michael's email found in 2026.

Q: How to contact Heiko Michael?

To contact Heiko Michael send an email to heiko.michael@googlemail.com or heiko.michael@sanofi-aventis.com. (updated on March 24, 2025)

Head QC, Sanofi Frankfurt Biologics & Oncology at Sanofi | Frankfurt, Hesse, Germany

About Heiko Michael

Heiko Michael currently serves as the Head of Quality Control at Sanofi Frankfurt Biologics & Oncology, where he plays a pivotal role in overseeing the quality assurance and analytical development processes for innovative biotechnologic drug substances. In this management-oriented position, Heiko leverages his extensive expertise in analytical development, validation, and quality control to ensure the highest standards of product safety, efficacy, and compliance with regulatory requirements such as FDA guidelines. His leadership is instrumental in driving complex key projects related to the release and stability testing of biologics, as well as process performance testing, which are critical for maintaining product integrity throughout the manufacturing lifecycle.

With over 15 years of experience in the pharmaceutical industry, Heiko has developed a deep understanding of laboratory operations, validation protocols, and SOP implementation within highly regulated environments. His team of approximately 115 biological and chemical laboratory technicians, biotechnologists, and scientists benefits from his strategic vision and hands-on approach to fostering a culture of continuous improvement, lean manufacturing, and technological transfer. Heiko’s expertise in HPLC, process validation, and laboratory management ensures that Sanofi’s biologics meet stringent quality standards while optimizing testing efficiency.

His comprehensive skill set encompasses quality control, laboratory management, validation, and regulatory compliance, making him a key driver of innovation and operational excellence in the biologics and oncology sectors. Through his leadership, Sanofi Frankfurt Biologics continues to advance its portfolio of cancer treatments, emphasizing robust quality systems and cutting-edge analytical techniques to support the development and commercialization of life-saving therapies.

Heiko Michael Work